Get started
Author

Sergi Camarillas

Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes for Patients with B-Cell Lymphoma
2023 · Gloria Iacoboni, Angel Serna, et al. · Blood · 16
Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma
2026 · Gloria Iacoboni, Emil Ramsø Kyvsgaard, et al. · Blood Advances · 8
PDF
Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma
2024 · Gloria Iacoboni, Emil Ramsø Kyvsgaard, et al. · Blood · 7
CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis
2026 · Victor Navarro, Gloria Iacoboni, et al. · Bone Marrow Transplantation · 4
Reduce Dose of Apixaban Vs. Standard of Care for Secondary Prevention in Cirrhotic Patients with Chronic Portal Vein Thrombosis
2024 · Marina Serra Carrera, Macarena Simón-Talero, et al. · Blood · 2
PDF
Ultra-Deep Sequencing of TP53 in Multiple Myeloma: Double-Hit Prevalence and Clinical Phenotype
2024 · Sandra Novoa Jáuregui, Maria Gabarros Subira, et al. · Blood · 1
PDF
SF3B1 mutation significance in myeloid neoplasms without anaemia
2026 · Sergi Camarillas, Xavier Calvo, et al. · British Journal of Haematology
PDF
Consolidative allogeneic HCT vs. a watch-and-wait approach for B-cell acute lymphoblastic leukemia patients with early loss of B-cell aplasia after CAR T-cell therapy
2026 · Sergi Camarillas, Anna Alonso-Saladrigues, et al. · Bone Marrow Transplantation
Early intervention for cytokine release syndrome after chimeric antigen receptor T-cell therapy is associated with an increased risk of cytopenias and infections in patients with large B-cell lymphoma
2025 · Gloria Iacoboni, Victor Navarro, et al. · Blood
PDF
Central nervous system relapse is uncommon after chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphoma
2025 · Gloria Iacoboni, Emmanuel Bachy, et al. · Blood
The cns-IPI score is predictive of severe immune effector cell-associated neurotoxicity after axicabtagene ciloleucel treatment in patients with large B-cell lymphoma
2025 · Sergi Camarillas, Samantha Feijoo, et al. · Blood
PDF
Beyond TP53: Molecular IPSS-genes multihit status revisited
2025 · Marina Serra Carrera, Lorenzo Carita, et al. · Blood
PDF
Specific Disease Entities - Mds With Ring Sideroblasts/sf3b1
2025 · Sergi Camarillas, Esther Alonso, et al. · Leukemia Research
ABCL-837: The CNS-IPI Score Is Predictive of the Risk of Severe ICANS After Axicabtagene Ciloleucel Treatment in Patients With Large B-Cell Lymphoma
2025 · Sergi Camarillas, Samantha Feijoo, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-837 The CNS-IPI Score Is Predictive of the Risk of Severe ICANS After Axicabtagene Ciloleucel Treatment in Patients With Large B-Cell Lymphoma
2025 · Sergi Camarillas, Samantha Feijoo, et al. · Clinical Lymphoma Myeloma & Leukemia
Clinical Outcomes of Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Autologous Chimeric Antigen Receptor T-Cell Therapy: A Meta-Analysis of 1,154 Patients Included in Clinical Trials
2024 · Pere Barba, Victor Navarro Garces, et al. · Blood
Donor Chimerism Monitorization for Relapse Prediction in Ex-Vivo CD34-Selected Allogenic Hematopoietic Stem Cell Transplant
2024 · Sergi Camarillas, Gilda Coralia Cetina Castro, et al. · Blood
PDF
SF3B1 Mutation Significance in Myeloid Neoplasms without Anemia
2024 · Sergi Camarillas, Esther Alonso, et al. · Blood
PDF
Long-Term Outcomes and Late Complications of Allogeneic Stem Cell Transplant with CD34+ Positive Selection in Adults with Acute Leukaemia and Myelodysplastic Syndrome: A Single-Centre Study
2024 · Elisa Roldan, Alba Puyuelo, et al. · Blood
PDF
Consolidative Allogenic Hematopoietic Cell Transplantation Vs. Watch and Wait Strategy for B-Cell Acute Lymphoblastic Leukemia Patients with Early Loss of B-Cell Aplasia after Chimeric Antigen Receptor T-Cell Therapy
2024 · Sergi Camarillas, Anna Alonso-Saladrigues, et al. · Blood
PDF
Works count: 20
Citation count: 38
H-index: 4
I10-index: 1
Year
Topic
Type